Literature DB >> 28214901

Protective Effects of Fluvastatin on Reproductive Function in Obese Male Rats Induced by High-Fat Diet through Enhanced Signaling of mTOR.

Xiangrong Cui, Chunlan Long, Jing Zhu, Jie Tian.   

Abstract

BACKGROUND: Statins can reduce reproductive damage induced by obesity or high-fat diet (HFD), but the specific regulatory mechanisms are largely unknown. Since mTOR/p70s6k sinaling promotes spermatogonia proliferation and spermatogenesis, we hypothesized that this pathway will be involved in the protective effects of statin in HFD-induced reproductive dysfunction.
METHODS: Male Sprague Dawley rats (3 weeks old) were randomly divided into a control group (standard diet), HFD group, and a fluvastatin group (HFD + fluvastatin at 6mg/kg, once daily by oral gavage). After 8 weeks, body weight was obtain and rats were sacrificed. Weights of the testes, gross morphology, sperm parameters, circulating levels of sex hormones, lipid levels, and tissue mTOR, p-P70s6k were measured. Another set of male rats were treated with rapamycin or vehicle. Flow cytometry was used to detect the spermatogonia marker c-kit and cell cycle. p-P70s6k expression was analyzed by Western blot.
RESULTS: HFD not only results in rat obesity but also leads to spermatogenetic damage and fluvastatin was able to partially block the effects of HFD. Fluvastatin also partially reversed the suppression of mTOR and p-p70s6k expresson.
CONCLUSION: Our data suggest that fluvastatin has protective effects on reproductive function in obese male rats most probably through enhanced signaling of mTOR.
© 2017 The Author(s)Published by S. Karger AG, Basel.

Entities:  

Keywords:  Fluvastatin; Obesity; Proliferation; Spermatogenesis; mTOR

Mesh:

Substances:

Year:  2017        PMID: 28214901     DOI: 10.1159/000457881

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  5 in total

1.  The difference in expression of long noncoding RNAs in rat semen induced by high-fat diet was associated with metabolic pathways.

Authors:  Tian An; Hui Fan; Yu F Liu; Yan Y Pan; Ying K Liu; Fang F Mo; Yu J Gu; Ya L Sun; Dan D Zhao; Na Yu; Yue Ma; Chen Y Liu; Qiu L Wang; Zheng Y Li; Fei Teng; Si Hua Gao; Guang J Jiang
Journal:  PeerJ       Date:  2017-07-25       Impact factor: 2.984

Review 2.  Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysis.

Authors:  Weimin Xie; Li Ning; Yuenan Huang; Yan Liu; Wen Zhang; Yingchao Hu; Jinghe Lang; Jiaxin Yang
Journal:  Oncotarget       Date:  2017-06-20

3.  The association between statin use and endometrial cancer survival outcome: A meta-analysis.

Authors:  Jia Li; Ruijuan Liu; Zhengdi Sun; Shifeng Tang; Lu Wang; Cun Liu; Wenge Zhao; Yan Yao; Changgang Sun
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

Review 4.  Metabolic Syndrome and Reproduction.

Authors:  Francesco Lotti; Sara Marchiani; Giovanni Corona; Mario Maggi
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

5.  The ameliorative effect of atorvastatin on serum testosterone and testicular oxidant/antioxidant system of HFD-fed male albino rats.

Authors:  Mohammed Esmail; Mohammed Kandeil; Ali Mahmoud El-Zanaty; Mohammed Abdel-Gabbar
Journal:  F1000Res       Date:  2020-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.